Literature DB >> 31819606

Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn.

Hao Xu1,2, Sha-Jie Dang3,4, Yuan-Yuan Cui1, Zhen-Yu Wu1, Jun-Feng Zhang2, Xiao-Peng Mei5, Yu-Peng Feng1, Yun-Qing Li1.   

Abstract

BACKGROUND AND
OBJECTIVE: Thalidomide (Tha) has been shown to exert immunomodulatory and anti-inflammatory properties. Whether Tha can alleviate spinal nerve ligation (SNL)-induced neuropathic pain (NP) is still unclear. This study aimed to investigate the therapeutic effect of Tha on the SNL-induced NP and further explore the potential analgesic mechanisms of Tha.
METHODS: The effects of Tha on SNL-induced mechanical allodynia were assessed by pain behavioral testing. The expressions of the astrocyte marker glial fibrillary acidic protein (GFAP) and the microglia marker Iba1 in the spinal dorsal horn were evaluated by immunofluorescence histochemistry. Protein expressions of the tumor necrosis factor alpha (TNF-α) in the spinal dorsal horn were tested by Western blot assay. Data were analyzed using one-way ANOVA or two-way ANOVA.
RESULTS: By the pretreatment with a single intraperitoneal injection, the PWMT in SNL+Tha group was significantly increased from day 1 to day 2 after SNL (P < 0.05 compared with SNL+Veh group). By the posttreatment with a single intraperitoneal injection, the PWMT in SNL+Tha group was also significantly increased from day 3 to day 4 after SNL (P < 0.05 compared with SNL+Veh group). By the posttreatment with multiple intraperitoneal injection, both the PWMT and the PWTL in SNL+Tha group were similarly significantly increased from day 3 to day 14 after SNL (P < 0.05 compared with SNL+Veh group). Furthermore, the GFAP and Iba1 expressions and TNF-α levels of the ipsilateral spinal dorsal horn in SNL+Tha group were significantly weaker from day 3 to day 14 after SNL than those in SNL+Veh group (P < 0.05).
CONCLUSION: Tha can significantly alleviate NP induced by SNL. The analgesic mechanism may be related to inhibition of astrocyte and microglia activation as well as down-regulation of TNF-α levels in the spinal dorsal horn.
© 2019 Xu et al.

Entities:  

Keywords:  Glia; TNF-α; Tha; neuropathic pain; spinal nerve ligation

Year:  2019        PMID: 31819606      PMCID: PMC6896366          DOI: 10.2147/JPR.S213112

Source DB:  PubMed          Journal:  J Pain Res        ISSN: 1178-7090            Impact factor:   3.133


  29 in total

1.  Treatment of severe esophageal Crohn's disease with thalidomide.

Authors:  P M Ginsburg; I Hanan; E D Ehrenpreis
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

2.  Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.

Authors:  T Parman; M J Wiley; P G Wells
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Nicotinic acetylcholine receptor agonism: progress in the management of neuropathic pain?

Authors:  Søren H Sindrup
Journal:  Pain       Date:  2009-10-08       Impact factor: 6.961

Review 4.  Nonneuronal central mechanisms of pain: glia and immune response.

Authors:  E Alfonso Romero-Sandoval; Sarah Sweitzer
Journal:  Prog Mol Biol Transl Sci       Date:  2015-02-02       Impact factor: 3.622

5.  Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.

Authors:  Matteo Bramuzzo; Gabriele Stocco; Marcella Montico; Serena Arrigo; Angela Calvi; Paola Lanteri; Stefano Costa; Salvatore Pellegrino; Giuseppe Magazzù; Jacopo Barp; Silvia Ghione; Paolo Lionetti; Giovanna Zuin; Massimo Fontana; Teresa Di Chio; Giuseppe Maggiore; Marzia Lazzerini; Marianna Lucafò; Chiara Udina; Maria Chiara Pellegrin; Andrea Chicco; Marco Carrozzi; Giuliana Decorti; Alessandro Ventura; Stefano Martelossi
Journal:  Inflamm Bowel Dis       Date:  2017-10       Impact factor: 5.325

6.  Effect of thalidomide on chemokine production by human microglia.

Authors:  J R Lokensgard; S Hu; E M van Fenema; W S Sheng; P K Peterson
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

Review 7.  Thalidomide: mechanisms of action.

Authors:  Taraneh Paravar; Delphine J Lee
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

Review 8.  Chronic Pain, Chronic Opioid Addiction: a Complex Nexus.

Authors:  Edwin A Salsitz
Journal:  J Med Toxicol       Date:  2016-03

9.  Clinical profile of multiple myeloma and effect of thalidomide based treatment on its outcome.

Authors:  S Sridhar; Tarun Kumar Dutta; Debdatta Basu
Journal:  J Indian Med Assoc       Date:  2011-12

Review 10.  Neuronal and microglial mechanisms of neuropathic pain.

Authors:  Min Zhuo; Gongxiong Wu; Long-Jun Wu
Journal:  Mol Brain       Date:  2011-07-30       Impact factor: 4.041

View more
  3 in total

1.  Bioinformatic Analysis of Neuroimmune Mechanism of Neuropathic Pain.

Authors:  Hao Yu; Yang Liu; Chao Li; Jianhao Wang; Bo Yu; Qiang Wu; Ziqian Xiang; Shiqing Feng
Journal:  Biomed Res Int       Date:  2020-08-28       Impact factor: 3.411

2.  Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4.

Authors:  Francesco De Logu; Gabriela Trevisan; Ilaria Maddalena Marone; Elisabetta Coppi; Diéssica Padilha Dalenogare; Mustafa Titiz; Matilde Marini; Lorenzo Landini; Daniel Souza Monteiro de Araujo; Simone Li Puma; Serena Materazzi; Gaetano De Siena; Pierangelo Geppetti; Romina Nassini
Journal:  BMC Biol       Date:  2020-12-14       Impact factor: 7.431

Review 3.  Pharmacological treatments of COVID-19.

Authors:  Adeleh Sahebnasagh; Razieh Avan; Fatemeh Saghafi; Mojataba Mojtahedzadeh; Afsaneh Sadremomtaz; Omid Arasteh; Asal Tanzifi; Fatemeh Faramarzi; Reza Negarandeh; Mohammadreza Safdari; Masoud Khataminia; Hassan Rezai Ghaleno; Solomon Habtemariam; Amirhosein Khoshi
Journal:  Pharmacol Rep       Date:  2020-08-20       Impact factor: 3.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.